Goodwin Belinda, Anderson Laura, Collins Katelyn, Sanjida Saira, Riba Marcos, Singh Gursharan K, Campbell Kimberley M, Green Heather, Ishaque Sana, Kwok Alastair, Opozda Melissa J, Pearn Amy, Shaw Joanne, Sansom-Daly Ursula M, Tsirgiotis Joanna M, Janda Monika, Grech Lisa
Viertel Cancer Research Centre, Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
Centre for Health Research, University of Southern Queensland, Springfield, Queensland, Australia.
Psychooncology. 2023 Dec;32(12):1773-1786. doi: 10.1002/pon.6238. Epub 2023 Nov 6.
To synthesize current evidence on the association between anticipatory anxiety, defined as apprehension-specific negative affect that may be experienced when exposed to potential threat or uncertainty, and cancer screening to better inform strategies to maximize participation rates.
Searches related to cancer screening and anxiety were conducted in seven electronic databases (APA PsycINFO, Scopus, Web of Science, Embase, Cochrane Library, PubMed, CINAHL), with potentially eligible papers screened in Covidence. Data extraction was conducted independently by multiple authors. Barriers to cancer screening for any type of cancer and relationships tested between anticipatory anxiety and cancer screening and intention were categorized and compared according to the form and target of anxiety and cancer types.
A total of 74 articles (n = 119,990) were included, reporting 103 relationships tested between anticipatory anxiety and cancer screening and 13 instances where anticipatory anxiety was reported as a barrier to screening. Anticipatory anxiety related to a possible cancer diagnosis was often associated with increased screening, while general anxiety showed no consistent relationship. Negative relationships were often found between anxiety about the screening procedure and cancer screening.
Anticipatory anxiety about a cancer diagnosis may promote screening participation, whereas a fear of the screening procedure could be a barrier. Public health messaging and primary prevention practitioners should acknowledge the appropriate risk of cancer, while engendering screening confidence and highlighting the safety and comfort of screening tests.
综合当前关于预期性焦虑（定义为在面临潜在威胁或不确定性时可能体验到的特定担忧的负面情绪）与癌症筛查之间关联的证据，以更好地为提高参与率的策略提供信息。
在七个电子数据库（美国心理学会心理学文摘数据库、Scopus、科学网、Embase、考克兰图书馆、PubMed、护理学与健康领域数据库）中进行了与癌症筛查和焦虑相关的检索，并在Covidence中筛选了可能符合条件的论文。由多位作者独立进行数据提取。根据焦虑的形式和目标以及癌症类型，对任何类型癌症的癌症筛查障碍以及预期性焦虑与癌症筛查和意愿之间的测试关系进行分类和比较。
共纳入74篇文章（n = 119,990），报告了预期性焦虑与癌症筛查之间测试的103种关系，以及13例预期性焦虑被报告为筛查障碍的情况。与可能的癌症诊断相关的预期性焦虑通常与筛查增加有关，而一般性焦虑则没有一致的关系。在对筛查程序的焦虑与癌症筛查之间经常发现负相关关系。
对癌症诊断的预期性焦虑可能会促进筛查参与，而对筛查程序的恐惧可能是一个障碍。公共卫生宣传和初级预防从业者应承认适当的癌症风险，同时增强筛查信心并强调筛查测试的安全性和舒适性。
